Skip to content

ACADIA Pharmaceuticals

US · ACAD #2404 by market cap Listed 1970
17.11 -0.48 -2.73%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1 1
■ Upgrades■ Downgrades
  • 1 upgrade vs 1 downgrade among tracked analyst rating changes.
  • Most recent: UBS moved from Buy to Hold on 2026-10-13.

Analyst consensus 13 analysts

Buy
Avg price target 31.77 +85.7%
Price target rangecurrent 17.11
Low23.00
Avg31.77
High38.00
Buy 77% Hold 23% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-13 Morgan Stanley -- Hold 24.00
2026-11-10 BofA Securities -- Buy 31.00
2026-11-09 BMO Capital -- Buy 34.00
2026-11-06 CCORF -- Buy 38.00
2026-11-05 TD Cowen -- Buy 37.00
2026-11-05 BofA Securities -- Buy --
2026-11-05 Morgan Stanley -- Hold 28.00
2026-11-05 Oppenheimer -- Hold 23.00
2026-11-05 RBC Capital -- Buy 38.00
2026-11-04 BMO Capital -- Buy 34.00
2026-10-19 Needham -- Buy 35.00
2026-10-14 UBS -- Hold 23.00
2026-10-13 UBS -- Hold 23.00
2026-10-12 BMO Capital -- Buy 34.00
2026-10-09 BofA Securities -- Buy 31.00
2026-10-08 RBC Capital -- Buy 36.00
2026-10-05 RBC Capital -- Buy 37.00
2026-09-25 CCORF -- Buy 36.00
2026-09-25 Citizens JMP -- Buy 33.00
2026-09-25 Deutsche Bank -- Buy 31.00
2026-09-25 Needham -- Buy 35.00
2026-09-25 BMO Capital -- Buy 34.00
2026-09-25 Citi -- Buy 33.00
2026-09-25 H.C. Wainwright -- Buy 33.00
2026-09-24 BofA Securities -- Buy 31.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-10-13 UBS Buy → Hold 23.00
2026-03-25 BofA Securities Hold → Buy 29.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 After close ±6.48% -1.07% (in line)
2026/Q2 2026-08-04 After close ±9.58% +6.08% (in line)
2026/Q1 2026-05-06 After close ±7.06% +5.03% (in line)
2025/Q4 2026-02-25 After close ±9.52% -1.32% (in line)
2025/Q3 2025-11-05 After close ±12.70% -3.05% (in line)
2025/Q2 2025-08-06 After close ±10.61% +2.52% (in line)
2025/Q1 2025-05-07 After close ±13.22% +14.31% (beat)
2024/Q4 2025-02-26 After close ±14.04% +1.79% (in line)
2024/Q3 2024-11-06 After close ±15.79% +8.93% (in line)
2024/Q2 2024-08-06 After close ±20.38% -19.52% (in line)
2024/Q1 2024-05-08 After close ±17.34% -11.21% (in line)
2023/Q4 2024-02-27 After close ±15.33% -9.92% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

ACADIA Pharmaceuticals discussion 0 comments

Add a comment